LBRX — LB Pharmaceuticals Inc.

Ownership history in Longbow Finance SA  ·  1 quarter on record

This page tracks every 13F SEC filing in which Longbow Finance SA reported a position in LB Pharmaceuticals Inc. (LBRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.31% (2025 Q4)
Avg. % of fund
0.31%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 82,336 — — 0.31% $1.8M $22.26
% of Fund (quarterly)    LBRX price (monthly, adj. close)

Other funds also holding LBRX

As of 2025 Q4 — sorted by position size

Nan Fung Group Holdings Ltd 3Y 5.98% Commodore Capital LP 3Y 2.22% Logos Global Management LP 3Y 1.61% Deep Track Capital, LP 3Y 1.33% TCG Crossover Management, LLC 3Y 1.29% Vivo Capital, LLC 3Y 7Y 1.15% HighVista Strategies LLC 3Y 7Y 0.8% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.5% Nantahala Capital Management, LLC 3Y 7Y 0.5% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.45%
← Back to Longbow Finance SA Holdings